Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman(The University of Melbourne), Nathan Lawrentschuk(Austin Health), Roslyn J. Francis(The University of Western Australia), Colin Tang(Sir Charles Gairdner Hospital), Ian Vela(Princess Alexandra Hospital), Paul Thomas(The University of Queensland), Natalie Rutherford(Hunter New England Local Health District), Jarad Martin(University of Newcastle Australia), Mark Frydenberg(Cabrini Hospital), Ramdave Shakher(Monash Health), Lih‐Ming Wong(The University of Melbourne), Kim Taubman(St Vincent's Health), Sze Ting Lee(Austin Health), Edward Hsiao(Royal North Shore Hospital), Paul Roach(The University of Sydney), Michelle Nottage(South Australian Health and Medical Research Institute), Ian Kirkwood(Royal Adelaide Hospital), Dickon Hayne(The University of Western Australia), Emma Link(The University of Melbourne), Petra Marušić(Peter MacCallum Cancer Centre), A Matera(Peter MacCallum Cancer Centre), Alan Herschtal(Peter MacCallum Cancer Centre), Amir Iravani(Peter MacCallum Cancer Centre), Rodney J. Hicks(Peter MacCallum Cancer Centre), Scott Williams(Australian and New Zealand Urogenital and Prostate Cancer Trials Group), Declan G. Murphy(Peter MacCallum Cancer Centre)
The Lancet
March 22, 2020
10.1016/s0140-6736(20)30314-7
Cited by 1,939

Abstract

Related Papers

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
Jérémie F. Cohen, Daniël A. Korevaar, Douglas G. Altman et al.|BMJ Open|2016|2.5k
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Piet Ost, Dries Reynders, Karel Decaestecker et al.|Journal of Clinical Oncology|2017|1.3k
Diagnostic Efficacy of <sup>68</sup> Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
Tobias Maurer, Jürgen E. Gschwend, Isabel Rauscher et al.|The Journal of Urology|2015|781
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
Scott E. Eggener, Peter T. Scardino, Patrick C. Walsh et al.|The Journal of Urology|2011|642
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
Ali Afshar‐Oromieh, Tim Holland‐Letz, Frederik L. Giesel et al.|European Journal of Nuclear Medicine and Molecular Imaging|2017|515